Thursday, February 13, 2020

Second antibiotic no advantage for treating super-bug Golden Staph

A world-first clinical trial has called into question the effectiveness of using more than one antibiotic to treat the deadly 'super-bug', Methicillin-resistant staphylococcus aureus (MRSA) Bacteremia, commonly known as Golden Staph.

from Top Health News -- ScienceDaily https://ift.tt/2UP1vVR
at
Labels:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

Breast cancer is surging among Asian American women — and scientists don’t know why

Breast cancer is rising rapidly among Asian American women, with some of the most alarming increases occurring in younger women and in aggre...